DeviceTalks Podcast Network

DeviceTalks Podcast Network

By DeviceTalks Podcast NetworkNewsHealth & FitnessTechnologyTech News
Download on the App Store

All DeviceTalks Podcast Network episodes

  • Where will Medtech innovation emerge in 2021? Hear from McCaney, Mejia and Morley
    The pandemic has accelerated innovation in many ways but the physical pressures on entrepreneurs, innovators and engineers is very real. In this episode of the DeviceTalks Weekly Podcast, a panel representing early-stage and tech transfer efforts explain how they're helping individuals and young companies work through the unique challenges of the time, including:
    *Finding capital
    *Working with corporates
    *Understanding opportunities in a changing healthcare market
    *Are there silver linings
    Guests include
    Jennifer McCaney, PhD,,co-executive director, UCLA Biodesign
    Jackie Mejia, PhD, director, gBeta Medtech
    Scott Morley, director, office of economic partnerships, University of Pittsburgh
    This conversation is a condensed version of our Jan. 19 DeviceTalks Tuesday. Go to DeviceTalks.com to watch the entire presentation.
    Co-host Chris Newmarker, executive editor of MassDevice, also shares his top 5 stories of the week, aka, NewmarkersNewsmakers. The big news belongs to DePuy, Philips, Boston Scientific, Transenterix and President Biden.
    58 min
  • Digging into the Digital Medtech & Surgical Worlds with Mark Toland, Scott Huennekens, and Kal Patel
    This week we’ll dig deep into digital surgery, robotics and the power of THE CLOUD.
    In our opening keynote conversation, Mark Toland, CEO of Medical Micro Instruments, explains why the company’s microsurgical robot has a chance to be in most hospitals. The company has CE Mark, a controlled commercial roll out and plans to knock in the FDA’s door sometime in 2022 where it will face huge competition (or, we think, potential acquirers if history holds out.) Watch the cool CNBC video here. https://www.cnbc.com/2020/10/28/italy-symani-surgical-robotic-system-improves-microsurgery-procedures.html
    Next, we talk with Scott “Go Go Go” Huennekens, employee number 1 at the former Verb Surgical, about the state of digital medtech. Huennekens, who previously led and sold Volcano Corp., explains why you can no longer have the latter without the former. Kal Patel, CEO of BrightInsight, explains why medtech must follow a different path – with equally unique challenges – to fully enjoy the power of digital connection.
    Danielle Kirsh, senior editor of Mass Device, drops by to bring us up to date at two cool devices presented at CES 2001. You can read about Omron and Binah.ai here.
    https://www.medicaldesignandoutsourcing.com/ces-2021-medical-technologies-you-need-to-know/
    Finally, Co-hosts Tom Salemi and Chris Newmarker walk through this week’s #NewmarkersNewsmakers featuring news from Abbott, Steris, Cantel and Theranos.
    1 hr 9 min
  • Medtronic’s Kowal on remote tech’s rebirth, SVB’s Norris delivers good news for VCs, CEOs
    Dr. Robert Kowal, CMO of Medtronic’s cardiac rhythm and heart failure business and vice president of medical affairs, explains how new tech, savvy patients, eager physicians and, yes, COVID-19, has fueled a renaissance for remote technology, once seen as a mature, staid business. Dr. Kowal also shares an amazing story of a patient who may owe his life to a timely conversation between his pacemaker and cellphone.
    Jon Norris, managing director of healthcare at Silicon Valley Bank, delivers three big takeaways from his report on 2020 fundraising. Medtech venture capitalists and start-ups didn’t let the lockdown slow their fund-raising efforts, and their efforts were buoyed by surprising strong exiting opportunities through IPOs and M&A.
    Co-hosts Chris Newmarker and Tom Salemi review the medtech industry’s response to the riot and occupation of the Capitol building. This week’s #NewmarkersNewsmakers includes news from Smith & Nephew, Stryker, and the disappearing Haven.
    51 min
  • Taking the fight to COVID-19 - BD, DHL, Novant on delivering, shipping and administering the vaccine
    Happy Vaccine Week!
    This week, we’ll visit with the medtech professionals who are working to get the vaccines into the right hands – and arms – of the people who need it most.
    This week’s guests include
    • Elizabeth Woody, Senior Vice President, Public Affairs at BD
    • Claudia Roa, Vice President Life Science & Healthcare Sector, Americas Global Customer Solutions at DHL
    • Eric Eskioğlu, MD, EVP & Chief Medical Officer, Novant Health
    Co-hosts Tom Salemi and Chris Newmarker welcome Brian Buntz, medtech pro and now pharma editor at WTWH Media, for a recap of the top 10 #newmarkersnewsmakers of 2020.
    We also look ahead to 2021 offering our Big, Bold Predictions for the New Year. (And someone offers to pick up the first round of drinks at DeviceTalks Boston in October…well, sort of.)
    This is the final episode of the DeviceTalks Weekly Podcast for 2020! Thanks to the tens of thousands (yep, really) people who have joined us on this audio journey.
    We’ll be back in January with a new DeviceTalks Weekly Podcast. Subscribe now so you don’t miss it!
    1 hr 9 min
  • Stryker CEO Kevin Lobo shares successful strategies for managing multiple crises (aka life in 2020)
    The past year of pandemic, social unrest and a divisive election - provided a crash course in crisis management for CEOs. In this week’s DeviceTalks Weekly Podcast, Kevin Lobo, the CEO of Stryker, explains how he led his company through this difficult year.
    His recipe for success is long, but it includes priorities, communication and listening.
    Lobo also is serving his final year as chairman of AdvaMed. He shares how that experience gave him an even better appreciation of the medtech industry, which he says got treated unfairly at times but still came through with high grades.
    Joining us for the first time as a co-host is Nancy Crotti, managing editor of Medical Design and Outsourcing. She’ll talk about the upcoming leadership issue.
    Meanwhile, Sean Whooley, assistant editor of MassDevice, will share the five big news items of the week aka #NewmarkersNewsmakers. This week’s news comes from Quest, Pfizer, Boston Scientific and Medtronic.
    And we'll learn which co-host had a steak cooked for them by a future president of the United States.
    Subscribe today on all your podcast players!
    47 min
  • Medtronic CEO Martha explains the why of competing, the reorg, and the importance of institutions
    In this episode of the DeviceTalks Weekly Podcast, Medtronic CEO Geoff Martha brings us on the inside of Medtronic’s ongoing reorganization. Martha explains how the new company will be structured to work with outside vendors. (Hint: more autonomy, not total autonomy.)
    He also explains why the company’s push to instill more competitive juice is aligned with its overarching mission of innovation.
    Martha also discussed his long path to medtech and Medtronic. How he first met Omar Ishrak and why institutions like Medtronic and other medtech companies need to step up on a social scale.
    This week, Dave Franchino, president of Delve, explains how the company is adapting innovation to fit the pandemic. (And suggests if you’re not finding opportunities to innovate, you’re simply not looking hard enough.)
    But there is no DeviceTalks party without Chris Newmarker, executive editor of MassDevice, who shares this episode’s Newmarker Newsmakers. Companies covered include Medtronic, Vectorious Medical Technologies, GE Healthcare, Stryker and Butterfly Network.
    Subscribe today you major podcast platforms!
    46 min
  • Enjoy a feast of insights from Spencer Stiles(Stryker) Art Collins(Explorer) and Mark Leahey (MDMA)
    DeviceTalks Weekly listeners will need some gravy to digest this Thanksgiving feast-sized podcast featuring news and insights from three stellar guests in addition to two new installments of #2minutedetalks chapters from Delve Inc. and Explorer Surgical.
    This week we visit with…
    Mark Leahey, president of the Medical Device Manufacturers Association, who explains where medtech might fits in this evolving political climate.
    Spencer Stiles, group president of orthopaedic and spine at Stryker, who shares details on the Wright acquisition and the secret to the success of placing MAKO surgical robots in hospitals
    Art Collins, senior advisor to Explorer Surgical. The former Chairman and CEO discusses leadership, Medtronic and the future for startups like Explorer.
    Also co-host Chris Newmarker, executive editor of MassDevice, shares his selections for this week’s #newmarkersnewsmakers which includes news from BD, Boston Scientific and Johnson & Johnson.
    1 hr 8 min
  • Vizient, Truist on how COVID-19 has changed healthcare’s appetite for buying medical devices
    This week’s DeviceTalks Weekly Podcast examines medtech’s readiness for the next COVID-19 surge.
    Hospitals are ready, but their appetite for expensive medical devices has changed, forcing medtech companies to change how they sell or lose out entirely.
    Justin Cassidy and Henry Soch of Vizient reveal why hospital executives are forced to divert funds away from new devices. They also explain how the power structure in capital purchases is shifting away from technology committees, creating a new challenge for medtech sales teams.
    Kaila Krum, managing director of Truist Securities, explains how companies like Stryker, Zimmer Biomet and Globus are successfully putting units in hospitals. She confirms medtech companies are being forced to evolve the way they work with hospitals.
    In the 2-minute-DeTalks, product development leader, podcast and president of Delve Dave Franchino joins us in a 2minute-detalks to explain how the company helps clients find the best solution to vexing problem. (Delve.com.)
    Explorer Surgical CEO Jennifer Fried makes the case for how her innovative start-ups tech company’s will not only connect surgeons with remote sales reps but also giving a broader view of how successful teams function.
    Chris Newmarker, executive editor of MassDevice, reveals his #NewmarkersNewsmakers highlighting contributions by Abbott, Stryker, Joe Biden, and EU-MDR.
    48 min
  • Where will Intuitive find future growth? Abbott’s Moat on how population boom will boost demand
    In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Intuitive Surgical's Julian Nikolchev, senior vice president, corporate development and strategy and Oliver Keown, MD, director of Intuitive Ventures, about the new $100 million venture fund. How will the capital be invested? Where does Intuitive see the opportunity, and how does the program fit into the robotic surgical company’s broader mandate to expand the profile of its product offerings? In our opening keynote, Neal Moat, MD, chief medical officer of Abbott’s structural heart business, talks about the success of the MitraClip and the impact COVID-19 is having on patients and Abbott personnel.
    Chris Newmarker, executive editor of MassDevice, will roll out his Newmarker’s Newsmakers including news about Abbott, Masimo and Stryker. Sean Whooley, assistant editor, will also give an earning wrap on the show highlighting interesting reports from Inspire Medical, Hologic, Stryker and Coloplast.
    DeviceTalks listeners are also invited to nominate their own Newmarker's Newsmakers of 2020. Use this online ballot to make your suggestions. We'll send out a ballot of the finalists later this month.
    Go to https://www.surveymonkey.com/r/MWDPVKD to vote!
    Subscribe today to receive future podcasts!
    58 min
  • Hear from Execs Katie Szyman, Naomi Murray, Start-Up CEO Patty Post & Evercore’s Vijay Kumar
    In this week’s episode of DeviceTalks Weekly the editorial team from MassDevice reviews the Medical Design & Outsourcing’s Women in Medtech issue bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical.
    Szyman will share Edwards’ view of artificial intelligence. Murray will share her future vision on additive manufacturing while Post will reveal the lessons learned in her first post as startup CEO of a diagnostic company.
    In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech?
    Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens. Senior Editor Danielle Kirsh also is on hand to talk through MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.
    48 min